Menu

Breakthrough Prizes for Life Scientists

Awards of $3 million each go to five researchers in the life sciences, recognizing their pioneering work on autophagy, DNA-damage response, Wnt signaling, and more.

Dec 5, 2016
Tracy Vence

Roeland Nusse accepts a Breakthrough Prize.TWITTER, STANFORD MEDICINEStephen Elledge of Harvard Medical School, the University of California, Santa Cruz’s Harry Noller, Roeland Nusse of Stanford University, Yoshinori Ohsumi of Tokyo Institute of Technology, and Huda Zoghbi of Baylor College of Medicine have won 2017 Breakthrough Prizes in Life Sciences. Each award, given yesterday (December 4) during a televised ceremony held in California, is worth $3 million.

Elledge is honored for his pioneering work on DNA-damage response. In 2015, he won a Lasker Award for basic medical research in recognition of his achievements in the field. “I’m truly honored to receive the Breakthrough Prize,” Elledge said in a statement. “It is deeply gratifying to see the profound impact that basic research can have not only in promoting scientific knowledge but also in improving human health.”

Noller is recognized “for discovering the centrality of RNA in forming the active centers of the ribosome,” according to the Breakthrough Prize announcement.

Nusse is honored for his work on Wnt signaling. “This is a complete surprise,” Nusse said in a press release. “My gratitude goes out to many people — my past and present postdoctoral scholars and graduate students and my former mentors have all contributed to the success of my research.”

Ohsumi, who this year won the Nobel Prize in Physiology or Medicine for his pioneering autophagy research, has won a Breakthrough Prize in recognition of his achievements in the field. In 2012, he won a Kyoto Prize in Basic Sciences.

Zoghbi is honored “for discoveries of the genetic causes and biochemical mechanisms of spinocerebellar ataxia and Rett syndrome, findings that have provided insight into the pathogenesis of neurodegenerative and neurological diseases,” according to the announcement. This year she won a Shaw Prize in Life Science and Medicine. “Sometimes rare diseases can really teach you something that's very helpful for more common diseases whose development and treatment has been elusive,” Zoghbi said during the Breakthrough Prize ceremony, according to The Washington Post.

Now in their fifth year, the Breakthrough Prizes are awarded annually to highlight achievements in the life sciences, mathematics, physics, and education. Winners are chosen by selection committees made up of previous Breakthrough Prize laureates.

“There has never been a more important time to support science,” Breakthrough Prize cofounder Mark Zuckerberg, chief executive officer of Facebook, said in the prize announcement. 

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.